AAAAAA

   
Results: 1-8 |
Results: 8
Recombinant human IGF-I does not modify the ACTH and cortisol responses tohCRH and hexarelin, a peptidyl GH secretagogue, in humans
Authors: Gianotti, L Ramunni, J Lanfranco, F Maccagno, B Giordano, R Broglio, F Maccario, M Muller, EE Ghigo, E Arvat, E
Citation: L. Gianotti et al., Recombinant human IGF-I does not modify the ACTH and cortisol responses tohCRH and hexarelin, a peptidyl GH secretagogue, in humans, J ENDOC INV, 24(2), 2001, pp. 67-71
Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans
Authors: Arvat, E Maccagno, B Giordano, R Pellegrino, M Broglio, F Gianotti, L Maccario, M Camanni, F Ghigo, E
Citation: E. Arvat et al., Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans, J CLIN END, 86(7), 2001, pp. 3176-3181
Interaction between glucagon and Hexarelin, a peptidyl GH secretagogue, onsomatotroph and corticotroph secretion in humans
Authors: Arvat, E Maccagno, B Ramunni, J Giordano, R Broglio, F Gianotti, L Maccario, M Camanni, F Ghigo, E
Citation: E. Arvat et al., Interaction between glucagon and Hexarelin, a peptidyl GH secretagogue, onsomatotroph and corticotroph secretion in humans, EUR J ENDOC, 143(5), 2000, pp. 601-606
Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans
Authors: Arvat, E Maccagno, B Ramunni, J Maccario, M Giordano, R Broglio, F Camanni, F Ghigo, E
Citation: E. Arvat et al., Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans, EUR J ENDOC, 143(1), 2000, pp. 99-104
Alprazolam. a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients
Authors: Grottoli, S Arvat, E Gauna, C Maccagno, B Ramunni, J Giordano, R Maccario, M Deghenghi, R Ghigo, E
Citation: S. Grottoli et al., Alprazolam. a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients, INT J OBES, 24, 2000, pp. S136-S137
Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease
Authors: Arvat, E Ramunni, J Giordano, R Maccagno, B Broglio, F Benso, A Deghenghi, R Ghigo, E
Citation: E. Arvat et al., Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease, J ENDOC INV, 22(1), 1999, pp. 23-28
Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease
Authors: Arvat, E Ramunni, J Maccagno, B Giordano, R Broglio, F Deghenghi, R Boscaro, M Ghigo, E
Citation: E. Arvat et al., Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease, NEUROENDOCR, 70(3), 1999, pp. 200-206
Influence of galanin and serotonin on the endocrine response to Hexarelin,a synthetic peptidyl GH-secretagogue, in normal women
Authors: Arvat, E Maccagno, B Ramunni, J Broglio, F Lanfranco, F Giordano, R Benso, A Deghenghi, R Ghigo, E
Citation: E. Arvat et al., Influence of galanin and serotonin on the endocrine response to Hexarelin,a synthetic peptidyl GH-secretagogue, in normal women, J ENDOC INV, 21(10), 1998, pp. 673-679
Risultati: 1-8 |